SYMBIOTEC PHARMALAB LTD Share Price

₹ 1,244.00

-₹6.20 (-0.5%)
1D
Last updated 30 Oct, 2026, 15:29 IST
NSE: SYMBIOTEC
|
Pharmaceuticals

SYMBIOTEC PHARMALAB LTD Share Price Today

As of 1 Nov 2026, SYMBIOTEC PHARMALAB LTD share price is ₹1,244.00. The stock opened at ₹1,250.00, compared to its previous close of ₹1,250.20. During today's trading session, SYMBIOTEC PHARMALAB LTD share price moved in the range of ₹1,217.00 to ₹1,267.50, with an average price of ₹1,242.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹934.20 and a high of ₹1,309.90. On the performance front, SYMBIOTEC PHARMALAB LTD share price has increased by 13.54% over the last six months and is up 13.54% on a year-on-year basis.

Share price over the last 1 day fell from 1260.90 to 1244.00, ranging between 1219.20 and 1265.00.
₹1,217.00
0.50% down today
₹1,267.50
1D LOW
1D HIGH

SYMBIOTEC PHARMALAB LTD Stock Insights

Latest Earning
Op Profit TrendUp by 4.34% YoY
Latest Earning
Net Profit TrendUp by 13.54% YoY
Latest Earning
Revenue TrendUp by 15.38% YoY
Stock Performance
OutperformingBeat Nifty by 8.29 % in last 1 month
Shareholding Pattern
DIIDII decreased stake by 4.50%
Shareholding Pattern
FIIFII decreased stake by 82.03%
SYMBIOTEC PHARMALAB LTD stock performance
Open₹1,250.00
High₹1,267.50
Low₹1,217.00
Prev. close₹1,250.20
SYMBIOTEC PHARMALAB LTD trading activity
Volume2,70,334
Average traded price₹1,238.97
Last traded time03:29:51 30 Oct
Last traded quantity15
Circuit
L
H
₹997.10
₹1,495.50
52-week
L
H
₹934.20
₹1,309.90
Mkt Cap Cr
8,000.85
P/E
0.0
P/B
0.0
ROA
7.01%
ROE
11.19%
ROCE
12.2%
Quick Ratio
0.47
EV/EBITDA
0.0

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Symbiotec Pharma outperforming all market indices
Valuation: 3 out of 5, Fairly Valued
Valuation
Fairly Valued
Symbiotec Pharma appears to be fairly valued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Symbiotec Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.7810.6%13.74%17.33%2.3121.44
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9115.68
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3518.95
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.520.71
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7424.79
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.22
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.72

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SYMBIOTEC PHARMALAB LTD Company Background

ISIN
INE899I01028
Sector Market Cap
₹ 8,000.85 Cr

SYMBIOTEC PHARMALAB LTD Financial Highlights

  • Revenue: SYMBIOTEC PHARMALAB LTD reported revenue of ₹872.26 crore in FY26 vs ₹755.98 crore in FY25. It showed an increase of 15.38% on a yearly basis.
  • Operating Profit: SYMBIOTEC PHARMALAB LTD reported an operating profit of ₹153.36 crore in FY26 vs ₹146.98 crore in FY25. It showed an increase of 4.34% on a year-on-year basis.
  • Net Profit: SYMBIOTEC PHARMALAB LTD reported a net profit of ₹109.90 crore in FY26 vs ₹96.79 crore in FY25. It showed an increase of 13.54% on a yearly basis.

SYMBIOTEC PHARMALAB LTD Quarterly Result Highlights

  • SYMBIOTEC PHARMALAB LTD reported revenue of ₹218.49 crore in Jun 2026, compared with ₹245.41 crore in Mar 2026, representing a decrease of 10.97% on a quarter-on-quarter (QoQ) basis.
  • SYMBIOTEC PHARMALAB LTD reported an operating profit of ₹17.53 crore in Jun 2026, compared with ₹35.25 crore in Mar 2026, representing a decrease of 50.27% on a quarter-on-quarter (QoQ) basis.
  • SYMBIOTEC PHARMALAB LTD reported a profit of ₹14.06 crore in Jun 2026, compared with ₹27.53 crore in Mar 2026, reflecting a decrease of 48.93% on a QoQ basis.
  • The earnings per share (EPS) of SYMBIOTEC PHARMALAB LTD stood at ₹19.10 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
33.28%
FII
3.79%
Other DII
20.99%
Retail and other
29.76%
Mutual funds
12.18%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Aug 202621.08%
Sep 20263.79%

SYMBIOTEC PHARMALAB LTD Investment Returns

1 day
-0.31%
1 week
+7.05%
1 month
+5.91%
1 year
+13.54%
3 years
+13.54%
5 years
+13.54%

SYMBIOTEC PHARMALAB LTD Share Price History

SYMBIOTEC PHARMALAB LTD share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹1,250.00 / ₹1,246.30
-0.31%
29 Oct 26
₹1,266.10 / ₹1,250.20
-1.92%
28 Oct 26
₹1,285.90 / ₹1,274.70
-0.24%
27 Oct 26
₹1,229.80 / ₹1,277.80
+3.90%
Show more

SYMBIOTEC PHARMALAB LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹869.15₹751.55₹716.25₹566.51
Other Income₹3.11₹4.43₹7.09₹6.46
Total Revenue₹872.26₹755.98₹723.33₹572.97
Total Expenses₹709.90₹608.85₹590.99₹533.63
Profit Before Tax₹153.36₹147.13₹132.35₹39.34
Tax₹43.46₹50.19₹30.93₹14.78
Profit After Tax₹109.90₹96.94₹101.42₹24.56
EPS - Basic₹19.10₹88.50₹91.49₹21.48
EPS - Diluted₹19.00₹88.50₹91.49₹21.48

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹153.36₹146.98₹132.35₹39.34
Income before WC changes₹238.78₹208.87₹172.11₹73.21
Change in Assets-₹34.80₹2.36-₹122.13₹20.10
Change in Liabilities₹32.32-₹129.15₹171.80-₹6.07
Change in WC-₹2.47-₹126.79₹49.67₹14.03
Cash flow from Operations₹174.59₹47.26₹187.50₹69.24
Cash flow from Investing-₹226.93-₹306.52-₹206.41-₹219.99
Cash flow from Financing₹35.99₹278.16₹21.85₹146.14
Total Cash Flow-₹16.35₹18.90₹2.94-₹4.61
Cash (Start of the year)₹26.39₹7.50₹4.55₹9.16
Cash (End of the year)₹10.04₹26.39₹7.50₹4.55

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,295.25₹1,086.79₹786.58₹589.82
Current Assets₹485.54₹492.86₹508.21₹400.17
Total Assets₹1,780.79₹1,579.65₹1,294.79₹989.99
Current Liabilities₹527.57₹472.60₹351.21₹228.07
Net Current Asset-₹42.02₹20.26₹157.00₹172.10
Non-Current Liabilities₹103.64₹292.35₹228.73₹140.48
Equity Capital₹1,149.59₹814.71₹714.84₹621.44
Total Equity & Liabilities₹1,780.79₹1,579.65₹1,294.79₹989.99

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹756.68₹673.61₹563.59₹633.85
Other Income₹32.00₹19.76₹12.37₹5.65
Total Revenue₹788.69₹693.37₹575.96₹639.50
Total Expenses₹592.66₹575.47₹519.16₹556.72
Profit Before Tax₹196.02₹117.90-₹7.78₹82.77
Tax₹50.19₹28.95₹14.88₹21.04
Profit After Tax₹145.83₹88.95-₹22.66₹61.73
EPS - Basic₹133.35₹81.33-₹20.72₹56.45
EPS - Diluted₹133.35₹81.33-₹20.72₹56.45

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹196.02₹117.90-₹7.78₹82.77
Income before WC changes₹225.76₹144.09₹83.38₹105.85
Change in Assets₹36.48-₹106.61₹26.35-₹38.27
Change in Liabilities-₹144.12₹145.07-₹0.56-₹20.63
Change in WC-₹107.64₹38.46₹25.80-₹58.89
Cash flow from Operations₹83.29₹147.46₹93.35₹23.62
Cash flow from Investing-₹291.79-₹80.80-₹132.50-₹33.94
Cash flow from Financing₹224.81-₹62.98₹36.53₹14.73
Total Cash Flow₹16.31₹3.67-₹2.62₹4.41
Cash (Start of the year)₹6.20₹2.53₹5.15₹0.74
Cash (End of the year)₹22.51₹6.20₹2.53₹5.15

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹869.80₹594.93₹528.49₹478.86
Current Assets₹479.23₹498.29₹386.62₹415.62
Total Assets₹1,349.04₹1,093.22₹915.12₹894.48
Current Liabilities₹346.32₹298.66₹214.19₹172.15
Net Current Asset₹132.92₹199.63₹172.43₹243.47
Non-Current Liabilities₹91.93₹33.43₹28.12₹27.15
Equity Capital₹910.79₹761.14₹672.81₹695.18
Total Equity & Liabilities₹1,349.04₹1,093.22₹915.12₹894.48
* All values are in INR Crore
SYMBIOTEC PHARMALAB LTD market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
SYMBIOTEC PHARMALAB LTD technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
48.63
Neutral
ATR (14)
64.61
Neutral
STOCH(9,6)
65.86
Neutral
STOCH RSI (14)
85.9
Bearish
ADX(9)
26.28
Bearish
UO(9)
58.04
Neutral
ROC(12)
6.25
Bullish
WillR(14)
-26.25
Neutral
Period
Simple value
Exponential vaue
5D
1255.76
1247
10D
1236.7
1232.34
20D
1199.17
1214.49
50D
1144.75
0
100D
1144.75
0
Volume trend — traded volume by day
30 Oct2L
29 Oct3L
28 Oct3L
27 Oct4L
26 Oct7L
Average4L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SYMBIOTEC PHARMALAB LTD
Pharmaceuticals
Add Stock
Add Another

SYMBIOTEC PHARMALAB LTD Returns Calculator

SYMBIOTEC PHARMALAB LTD Latest News

1 month ago
Symbiotec Pharmalab shares jump 6% as subsidiary secures distribution rights for injectable product in US
1 month ago
Coforge, Azad Eng, NCC, AXISCADE among buzzing stocks as SENSEX falls 400 pts; NIFTY trades below 22,700
Showing news item 1 of 2

Top Gainers

LAURUSLABS Share Price
₹2405.50
+161.5 (+7.2%)
TRENT Share Price
₹3017.30
+155.6 (+5.44%)
ZYDUSLIFE Share Price
₹1245.50
+61.1 (+5.16%)
NAVINFLUOR Share Price
₹8680.00
+419.5 (+5.08%)
POONAWALLA Share Price
₹461.70
+20.2 (+4.58%)
See more

Top Losers

INTELLECT Share Price
₹504.55
-98.3 (-16.31%)
REDINGTON Share Price
₹326.95
-30.2 (-8.46%)
SUZLON Share Price
₹33.90
-2.89 (-7.86%)
COHANCE Share Price
₹444.30
-37.05 (-7.7%)
PNCINFRA Share Price
₹123.93
-10.05 (-7.5%)
See more

SYMBIOTEC PHARMALAB LTD Share Price FAQs

Please be aware that SYMBIOTEC PHARMALAB LTD stock prices are subject to continuous fluctuations due to various factors.